TransMedics (TMDX) EBIT Margin Growth (3y) (2021 - 2026)
Powered by 
Analysis
TransMedics (TMDX) EBIT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 244.00 |
| 10 | TransMedics | 2.98 Bn | 2.51 Bn | 113.20 Mn | 1,422.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,422.00 |
| Mar 31, 2026 | 1,267.00 |
| Dec 31, 2025 | 3,484.00 |
| Sep 30, 2025 | 3,779.00 |
| Jun 30, 2025 | 7,072.00 |
| Mar 31, 2025 | 7,812.00 |
| Dec 31, 2024 | 13,968.00 |
| Sep 30, 2024 | 22,022.00 |
| Jun 30, 2024 | 12,480.00 |
| Mar 31, 2024 | 9,803.00 |
| Dec 31, 2023 | 8,051.00 |
| Sep 30, 2023 | 1,517.00 |
| Jun 30, 2023 | 19,866.00 |
| Mar 31, 2023 | 9,223.00 |
| Dec 31, 2022 | 12,193.00 |
| Sep 30, 2022 | 7,893.00 |
| Jun 30, 2022 | 8,850.00 |
| Mar 31, 2022 | 6,850.00 |
| Dec 31, 2021 | 4,692.00 |
| Sep 30, 2021 | -11,908.00 |